Skip to content

Finished goods at other companies

Danaher logo
DanaherDHR
Agilent Technologies logo
Agilent TechnologiesA
Charles River Laboratories logo
Charles River LaboratoriesCRL
Idexx Laboratories logo
Idexx LaboratoriesIDXX
Bruker logo
BrukerBRKR
Illumina logo
IlluminaILMN

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s finished goods?
Bio-Rad Laboratories, Inc. (BIO.B) reported finished goods of $330.3M in Q1 2026.
How has Bio-Rad Laboratories, Inc.'s finished goods changed year-over-year?
Bio-Rad Laboratories, Inc.'s finished goods increased by 4.7% year-over-year, from $315.5M to $330.3M.
What is the long-term trend for Bio-Rad Laboratories, Inc.'s finished goods?
Over 5 years (2020 to 2025), Bio-Rad Laboratories, Inc.'s finished goods has grown at a -3.1% compound annual growth rate (CAGR), from $343.41M to $293.3M.
What does finished goods mean?
Completed products ready for sale, valued at the lower of cost or net realizable value.